Mathys & Squire, a UK Intellectual Property (IP) firm, is expanding its Manchester office with the appointment of Dr David Martin, a senior European and UK patent attorney.
An expert in IP relating to life sciences, chemistry, and medical devices, Martin brings valuable experience to the growing team of patent and trademark attorneys in the firm’s Manchester office.
Martin conducted post-doctoral research at the University of California (Berkeley) and at Oxford University before transferring his technical expertise to IP. He has a wealth of experience in providing IP advice to companies and organisations based in the north west of the UK and internationally.
In spite of continuing economic challenges in the UK, Mathys & Squire’s Manchester practice has grown consistently since 2008.
‘The firm is still expanding and investing in the region, and we intend to recruit more key patent attorneys across all disciplines, in particular life sciences, IT and engineering,’ said HR manager Roger Herrington.
IP specialist Mathys & Squire expands
Appoints Dr David Martin at Manchester office
You may also like
Digital
Pharma cybersecurity challenges: a holistic prescription
The pharmaceutical sector remains a prime target for cyberattacks. As an industry built on innovation, with extensive investments in research and development (R&D), intellectual property (IP) and patient information, it bridges the divide between business and healthcare, becoming a hotspot in the health data threat landscape
Pharmaceutical
A card in the competition for COVID-19 drug supply
The patent system has come under pressure both politically and, more recently, as pharma companies scale-up their operations to make large amounts of drugs available to treat COVID-19, reports Paul England, Senior Professional Support Lawyer at Taylor Wessing
Ingredients
Sigrid Therapeutics obtains US patent for silica-based biomaterial SiPore15 for the treatment and prevention of obesity
Mesoporous silica particles (MSP) are a type of ingestible synthetic amorphous silica particles that can be produced with a large surface area and a range of pore sizes